Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Dec. 05, 2020	Nov. 30, 2019
Cash flows from operating activities:
Net income	$ 994.4	$ 398.6
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on property dispositions and impairment losses, net	(47.0)	(482.7)
Depreciation and amortization	1,171.7	1,281.9
Operating lease right-of-use assets amortization	443.9	418.3
LIFO expense	37.5	18.9
Deferred income tax	(16.8)	(40.6)
Contributions to pension and post-retirement benefit plans, net of (income) expense	(80.6)	(16.2)
Loss on interest rate swaps and commodity hedges, net	24.0	0.4
Amortization and write-off of deferred financing costs	16.1	35.4
Loss on debt extinguishment	57.7	65.8
Equity-based compensation expense	43.4	24.8
Other	(46.0)	8.5
Changes in operating assets and liabilities:
Receivables, net	(23.1)	84.9
Inventories, net	(322.9)	(310.4)
Accounts payable, accrued salaries and wages and other accrued liabilities	627.1	322.4
Operating lease liabilities	(357.7)	(385.5)
Self-insurance assets and liabilities	20.6	5.5
Other operating assets and liabilities	453.7	(43.0)
Net cash provided by operating activities	2,996.0	1,387.0
Cash flows from investing activities:
Payments for property, equipment and intangibles, including payments for lease buyouts	(1,083.0)	(1,083.7)
Proceeds from sale of assets	143.9	1,061.0
Other	(5.2)	(2.7)
Net cash used in investing activities	(944.3)	(25.4)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	3,500.0	1,518.0
Payments on long-term borrowings	(3,638.7)	(3,300.8)
Payments of obligations under finance leases	(52.0)	(78.3)
Payment of redemption premium on debt extinguishment	(48.6)	0.0
Payments for debt financing costs	(15.9)	(25.5)
Dividends paid on common stock	(47.3)	0.0
Accrued dividends on Convertible Preferred Stock	(36.4)	0.0
Proceeds from convertible preferred stock	1,680.0	0.0
Third party issuance costs on convertible preferred stock	(80.9)	0.0
Treasury stock purchase, at cost	(1,864.7)	0.0
Other	(39.4)	(26.1)
Net cash used in financing activities	(643.9)	(1,912.7)
Net increase (decrease) in cash and cash equivalents and restricted cash	1,407.8	(551.1)
Cash and cash equivalents and restricted cash at beginning of period	478.9	967.7
Cash and cash equivalents and restricted cash at end of period	$ 1,886.7	$ 416.6